Availability of Nutritional Support Services in HIV Care and Treatment Sites in Sub-Saharan African Countries
Overview
Authors
Affiliations
Objective: To examine the availability of nutritional support services in HIV care and treatment sites across sub-Saharan Africa.
Design: In 2008, we conducted a cross-sectional survey of sites providing antiretroviral therapy (ART) in nine sub-Saharan African countries. Outcomes included availability of: (i) nutritional counselling; (ii) micronutrient supplementation; (iii) treatment for severe malnutrition; and (iv) food rations. Associations with health system indicators were explored using bivariate and multivariate methods.
Setting: President's Emergency Plan for AIDS Relief-supported HIV treatment and care sites across nine sub-Saharan African countries.
Subjects: A total of 336 HIV care and treatment sites, serving 467 175 enrolled patients.
Results: Of the sites under study, 303 (90 %) offered some form of nutritional support service. Nutritional counselling, micronutrient supplementation, treatment for severe acute malnutrition and food rations were available at 98 %, 64 %, 36 % and 31 % of sites, respectively. In multivariate analysis, secondary or tertiary care sites were more likely to offer nutritional counselling (adjusted OR (AOR): 2.2, 95 % CI 1.1, 4.5). Rural sites (AOR: 2.3, 95 % CI 1.4, 3.8) had increased odds of micronutrient supplementation availability. Sites providing ART for >2 years had higher odds of availability of treatment for severe malnutrition (AOR: 2.4, 95 % CI 1.4, 4.1). Sites providing ART for >2 years (AOR: 1.6, 95 % CI 1.3, 1.9) and rural sites (AOR: 2.4, 95 % CI 1.4, 4.4) had greater odds of food ration availability.
Conclusions: Availability of nutritional support services was high in this large sample of HIV care and treatment sites in sub-Saharan Africa. Further efforts are needed to determine the uptake, quality and effectiveness of these services and their impact on patient and programme outcomes.
Apprey C, Addae H, Osei M, Danquah I, Annan R BMC Infect Dis. 2025; 25(1):1.
PMID: 39743519 PMC: 11694380. DOI: 10.1186/s12879-024-10395-z.
Yumo H, Ndenkeh J, Beissner M HIV AIDS (Auckl). 2023; 15:663-670.
PMID: 38028191 PMC: 10644811. DOI: 10.2147/HIV.S417852.
Schwartz N, Yilma D, Girma T, Tesfaye M, Molgaard C, Michaelsen K Food Nutr Res. 2022; 66.
PMID: 35291724 PMC: 8886435. DOI: 10.29219/fnr.v66.5659.
Geng S, Zhang J, Wang Y, Xu Y, Lu D, Zhang Z Front Immunol. 2022; 12:757935.
PMID: 35003070 PMC: 8741150. DOI: 10.3389/fimmu.2021.757935.
Tesfay F, Javanparast S, Gesesew H, Mwanri L, Ziersch A BMJ Open. 2022; 12(1):e047205.
PMID: 34987036 PMC: 8734022. DOI: 10.1136/bmjopen-2020-047205.